President Joe Biden, who has challenged the pharmaceutical industry for decades, joined Sen. Bernie Sanders’ clash with Novo Nordisk in a July 2 op-ed published in USA Today.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
